Cder - integrating sentinel capabilities into cder regulatory workflows
Ended Awarded Last action
- Contract number
- HHSF22315005
- Awardee
-
Mckinsey & Company, Inc. Washington D.c. UEI N6JZARL64EW5 Part of Mckinsey & Company, Inc.
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $2,641,441
Award facts
- Contract value 100% obligated
- $2,641,440.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20857, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$29,028 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $599,928 | |
| Additional Work (new agreement, FAR part 6 applies) | $685,896 | |
| Other Administrative Action | $0 | |
| Original award | $1,384,644 |
About this award
This federal contract award was made by the Food and Drug Administration (FDA) to McKinsey & Company, Inc. Washington D.C. for the project "CDER - INTEGRATING SENTINEL CAPABILITIES INTO CDER REGULATORY WORKFLOWS". The $2,641,440.88 contract is a Blanket Purchase Agreement (BPA) Call under the General Services Administration's (GSA) Professional Services Schedule (PSS), with a firm fixed price. The contract does not have a set-aside designation. McKinsey, a global management consulting firm, will provide strategic advisory services to the FDA's Center for Drug Evaluation and Research (CDER) to integrate Sentinel capabilities into regulatory workflows. Sentinel is the FDA's national medical product safety surveillance program. This contract is part of McKinsey's broader federal contracting activities, which span high-priority initiatives across defense and civilian agencies, including pandemic response, strategic transformation, and modernization efforts.
Quick answers
Who was awarded contract HHSF22315005?
HHSF22315005 was awarded to Mckinsey & Company, Inc. Washington D.c. by Food and Drug Administration (Department of Health and Human Services) on July 15, 2015.
How much is contract HHSF22315005 worth?
The government has obligated $2,641,441 on HHSF22315005.
Is contract HHSF22315005 an order under another contract?
Yes. HHSF22315005 is a BPA call under GS10F0118S-HHSF223201010014B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract HHSF22315005 competed?
The extent of competition for HHSF22315005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award